91ɫƬ

New Alzheimer’s drug takes new approach

Reports of patients "waking up" within minutes of receiving a drug called etanercept have created a stir, but the research has yet to be published

WHAT should we make of stories and TV footage this week claiming that Alzheimer’s patients “woke up” and became compos mentis within minutes of being injected in the neck with the anti-arthritis drug etanercept?

Unusually, the treatment doesn’t target the protein plaques which clog up the brains of people with Alzheimer’s and are believed to destroy brain tissue. Instead, the aim is to ease brain inflammation, which Edward Tobinick, pioneer of the new treatment at the Institute for Neurological Research in California, thinks is the real cause. He argues that inflammation blocks signalling between brain cells, and that is why getting rid of it has such a dramatic effect.

So will attacking inflammation succeed where combating plaque has failed? “This is a tremendous paradigm shift,” Tobinick told New Scientist. “It is exciting work and we are just scratching the surface.”

The UK urged caution. “We cannot draw any conclusions until a controlled trial is carried out,” said Susanne Sorensen, the society’s head of research. New Scientist will publish a fuller report soon.

Mental 91ɫƬ – Discover the latest research in our continuously updated special report.

Topics: Mental health